Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol vs Propranolol for Secondary Prophylaxis in Cirrhosis
NCT02385422Phase 4Unknown
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Mar 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of carvedilol in esophageal and gastric varices (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Endoscopic Retreatment at 6 months. Status: unknown.
02
Drugs
carvedilol
03
Conditions
esophageal and gastric varices
Beyond the preview
Go deeper on NCT02385422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02385422.